Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5

被引:241
作者
Epperson, C. Neill [1 ]
Steiner, Meir
Hartlage, S. Ann
Eriksson, Elias
Schmidt, Peter J.
Jones, Ian
Yonkers, Kimberly A.
机构
[1] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
基金
加拿大健康研究院;
关键词
LATE LUTEAL-PHASE; COMMUNITY-BASED SAMPLE; LONG-TERM TREATMENT; MENSTRUAL-CYCLE; SYMPTOM SEVERITY; ENVIRONMENTAL-FACTORS; SERTRALINE TREATMENT; STARTLE RESPONSE; MOOD DISORDER; DOUBLE-BLIND;
D O I
10.1176/appi.ajp.2012.11081302
中图分类号
R749 [精神病学];
学科分类号
100204 [神经病学];
摘要
Premenstrual dysphoric disorder, which affects 2%-5% of premenopausal women, was included in Appendix B of DSMIV, "Criterion Sets and Axes Provided for Further Study." Since then, aided by the inclusion of specific and rigorous criteria in DSM-IV, there has been an explosion of research on the epidemiology, phenomenology, pathogenesis, and treatment of the disorder. In 2009, the Mood Disorders Work Group for DSM-5 convened a group of experts to examine the literature on premenstrual dysphoric disorder and provide recommendations regarding the appropriate criteria and placement for the disorder in DSM-5. Based on thorough review and lengthy discussion, the work group proposed that the information on the diagnosis, treatment, and validation of the disorder has matured sufficiently for it to qualify as a full category in DSM-5. A move to the position of category, rather than a criterion set in need of further study, will provide greater legitimacy for the disorder and encourage the growth of evidence-based research, ultimately leading to new treatments.
引用
收藏
页码:465 / 475
页数:11
相关论文
共 103 条
[1]
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[2]
MOOD, SEXUALITY, HORMONES, AND THE MENSTRUAL-CYCLE .2. HORMONE LEVELS AND THEIR RELATIONSHIP TO THE PRE-MENSTRUAL SYNDROME [J].
BACKSTROM, T ;
SANDERS, D ;
LEASK, R ;
DAVIDSON, D ;
WARNER, P ;
BANCROFT, J .
PSYCHOSOMATIC MEDICINE, 1983, 45 (06) :503-507
[3]
THE USE OF AN LHRH AGONIST, BUSERELIN, IN THE LONG-TERM MANAGEMENT OF PREMENSTRUAL SYNDROMES [J].
BANCROFT, J ;
BOYLE, H ;
WARNER, P ;
FRASER, HM .
CLINICAL ENDOCRINOLOGY, 1987, 27 (02) :171-182
[4]
Banerjee N, 2000, INT J FERTIL WOMEN M, V45, P342
[5]
Pituitary-adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls [J].
Bloch, M ;
Schmidt, PJ ;
Su, TP ;
Tobin, MB ;
Rubinow, DR .
BIOLOGICAL PSYCHIATRY, 1998, 43 (12) :897-903
[6]
Premenstrual syndrome: Evidence for symptom stability across cycles [J].
Bloch, M ;
Schmidt, PJ ;
Rubinow, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (12) :1741-1746
[7]
BROWN CS, 1994, OBSTET GYNECOL, V84, P779
[8]
Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women - The Harvard Study of Moods and Cycles [J].
Cohen, LS ;
Soares, CN ;
Otto, MW ;
Sweeney, BH ;
Liberman, RF ;
Harlow, BL .
JOURNAL OF AFFECTIVE DISORDERS, 2002, 70 (02) :125-132
[9]
Premenstrual daily fluoxetine for premenstrual dysphoric disorder: A placebo-controlled, clinical trial using computerized diaries [J].
Cohen, LS ;
Miner, C ;
Brown, E ;
Freeman, EW ;
Halbreich, U ;
Sundell, K ;
McCray, S .
OBSTETRICS AND GYNECOLOGY, 2002, 100 (03) :435-444
[10]
THE PREMENSTRUAL-SYNDROME - A TWIN STUDY [J].
CONDON, JT .
BRITISH JOURNAL OF PSYCHIATRY, 1993, 162 :481-486